TJ Cradick

Company: Gene Editing Frontiers

Job title: Chief Scientific Officer

Seminars:

Morning Workshop: Expanding Rare Disease Targeting Using Lessons Learned from Baby KJ’s Personalized CRISPR Therapy 9:30 am

Following the groundbreaking work to launch the world's first personalized CRISPR therapy to treat baby KJ, a new blueprint for rare disease treatment is forming. This interactive workshop with the baby KJ team offers unmissable insights into how this pioneering approach to precision medicine has created a transformative model for targeting rare diseases more effectively…Read more

day: Day Two